Covid-19 antiviral pilots

The government announced this month that thousands of the UK’s most vulnerable people will be among the first in the world to access a new antiviral treatment for Covid-19, Molnupiravir. This will take the form of pilot prescribing antivirals to vulnerable people who have caught Covid-19 and a study combining providing antivirals and placebos to healthier people. The Government press release announcing these can be read here.

NHS antiviral prescribing for vulnerable patients

The NHS has confirmed that it will begin offering Molnupiravir from 16 December, to patients who are at the highest risk of becoming seriously ill with coronavirus. Those eligible must be over 12 years old and live with a condition that makes Covid-19 especially dangerous, such as Down’s Syndrome or certain types of cancer. If the NHS considers the antiviral treatment appropriate for an individual, a hospital pharmacy will arrange for the medicine to be delivered to your home. Molnupiravir is administered in capsules to be swallowed.

The full list of eligible patients and more details for the public can be read here. Eligibility closely corresponds to the shielding list criteria used earlier in the pandemic. Further information from the MHRA can be accessed here.

Study of antiviral use in healthy patients

Separately, the University of Oxford, in close collaboration with GP hubs, has launched a national study called PANORAMIC, which will provide 10,000 people with the opportunity to take Molnupiravir at home after testing positive. To participate in the study, individuals must be aged 50 or over or have a pre-existing health condition. 215 participants have currently been recruited across 21 NHS sites across the UK. If eligible, individuals who have tested positive will be contacted by the study team or a local healthcare professional, such as their GP. People can also find out if they meet the requirements at www.panoramictrial.org.

 

 

Last updated : 16 Dec 2021

 

Registering overseas vaccinations at vaccination sites (16 Dec 2021)

On 9 December the Government updated guidance advising patients who wish to add an overseas Covid-19 vaccination to their NHS record to do so by booking a specific type of...
Read more »

Guidance updates December 2021 (16 Dec 2021)

The most important pieces of guidance released for general practice since our last newsletter are: Regulatory approval of Pfizer/BioNTech vaccine for COVID-19 and Regulatory approval of Spikevax...
Read more »

PCSE updates on contact details and pooled lists (16 Dec 2021)

Correct contact details Practices can improve communications with PCSE by ensuring that they have the most up to date practice contact details, including: The main practice contact All user...
Read more »

MP engagement and government consultations (16 Dec 2021)

During late November and December 2021 representatives from Londonwide LMCs have continued to meet with MPs, councillors and the police to raise issues affecting practices. We have also submitted evidence...
Read more »

Tips of the month December 2021 (16 Dec 2021)

We provide weekly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...
Read more »

Dr Michelle Drage’s Christmas and New Year message (16 Dec 2021)

Thank you for simply still being here after the year you and all London general practices have had. With relentless pressure coming from clinically necessary activity, and the equally relentless...
Read more »

Annual General Meeting for Londonwide LMCs and Londonwide Enterprise Ltd (16 Dec 2021)

The Annual General Meeting for Londonwide LMCs and Londonwide Enterprise Ltd will be held on Thursday 20 January 2022 between 2:00pm and 3.15pm.  The AGM is a chance to meet...
Read more »

Mandatory vaccination of practice staff – what we know so far (10 Dec 2021)

Friday 10 December 2021 Dear Colleague, Mandatory vaccination of...
Read more »
Next Page »